1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Artificial Blood Substitute Revenue
1.4 Market Analysis by Type
1.4.1 Global Artificial Blood Substitute Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Perfluorocarbon-based Oxygen Carrier (PFBOC)
1.4.3 Hemoglobin-based Oxygen Carrier (HBOC)
1.5 Market by Application
1.5.1 Global Artificial Blood Substitute Market Share by Application: 2021-2026
1.5.2 Military
1.5.3 Civil
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Artificial Blood Substitute Market
1.8.1 Global Artificial Blood Substitute Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Artificial Blood Substitute Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Artificial Blood Substitute Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Artificial Blood Substitute Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Artificial Blood Substitute Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Artificial Blood Substitute Sales Volume Market Share by Region (2015-2020)
3.2 Global Artificial Blood Substitute Sales Revenue Market Share by Region (2015-2020)
3.3 North America Artificial Blood Substitute Sales Volume
3.3.1 North America Artificial Blood Substitute Sales Volume Growth Rate (2015-2020)
3.3.2 North America Artificial Blood Substitute Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Artificial Blood Substitute Sales Volume
3.4.1 East Asia Artificial Blood Substitute Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Artificial Blood Substitute Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Artificial Blood Substitute Sales Volume (2015-2020)
3.5.1 Europe Artificial Blood Substitute Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Artificial Blood Substitute Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Artificial Blood Substitute Sales Volume (2015-2020)
3.6.1 South Asia Artificial Blood Substitute Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Artificial Blood Substitute Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Artificial Blood Substitute Sales Volume (2015-2020)
3.7.1 Southeast Asia Artificial Blood Substitute Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Artificial Blood Substitute Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Artificial Blood Substitute Sales Volume (2015-2020)
3.8.1 Middle East Artificial Blood Substitute Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Artificial Blood Substitute Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Artificial Blood Substitute Sales Volume (2015-2020)
3.9.1 Africa Artificial Blood Substitute Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Artificial Blood Substitute Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Artificial Blood Substitute Sales Volume (2015-2020)
3.10.1 Oceania Artificial Blood Substitute Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Artificial Blood Substitute Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Artificial Blood Substitute Sales Volume (2015-2020)
3.11.1 South America Artificial Blood Substitute Sales Volume Growth Rate (2015-2020)
3.11.2 South America Artificial Blood Substitute Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Artificial Blood Substitute Sales Volume (2015-2020)
3.12.1 Rest of the World Artificial Blood Substitute Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Artificial Blood Substitute Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Artificial Blood Substitute Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Artificial Blood Substitute Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Artificial Blood Substitute Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Artificial Blood Substitute Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Artificial Blood Substitute Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Artificial Blood Substitute Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Artificial Blood Substitute Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Artificial Blood Substitute Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Artificial Blood Substitute Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Artificial Blood Substitute Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Artificial Blood Substitute Sales Volume Market Share by Type (2015-2020)
14.2 Global Artificial Blood Substitute Sales Revenue Market Share by Type (2015-2020)
14.3 Global Artificial Blood Substitute Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Artificial Blood Substitute Consumption Volume by Application (2015-2020)
15.2 Global Artificial Blood Substitute Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Artificial Blood Substitute Business
16.1 Aurum Biosciences Ltd.
16.1.1 Aurum Biosciences Ltd. Company Profile
16.1.2 Aurum Biosciences Ltd. Artificial Blood Substitute Product Specification
16.1.3 Aurum Biosciences Ltd. Artificial Blood Substitute Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 KaloCyte Inc.
16.2.1 KaloCyte Inc. Company Profile
16.2.2 KaloCyte Inc. Artificial Blood Substitute Product Specification
16.2.3 KaloCyte Inc. Artificial Blood Substitute Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 HEMARINA SA
16.3.1 HEMARINA SA Company Profile
16.3.2 HEMARINA SA Artificial Blood Substitute Product Specification
16.3.3 HEMARINA SA Artificial Blood Substitute Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 HbO2 Therapeutics
16.4.1 HbO2 Therapeutics Company Profile
16.4.2 HbO2 Therapeutics Artificial Blood Substitute Product Specification
16.4.3 HbO2 Therapeutics Artificial Blood Substitute Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 NuvOx Pharma
16.5.1 NuvOx Pharma Company Profile
16.5.2 NuvOx Pharma Artificial Blood Substitute Product Specification
16.5.3 NuvOx Pharma Artificial Blood Substitute Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 SpheriTech Ltd.
16.6.1 SpheriTech Ltd. Company Profile
16.6.2 SpheriTech Ltd. Artificial Blood Substitute Product Specification
16.6.3 SpheriTech Ltd. Artificial Blood Substitute Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Artificial Blood Substitute Manufacturing Cost Analysis
17.1 Artificial Blood Substitute Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Artificial Blood Substitute
17.4 Artificial Blood Substitute Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Artificial Blood Substitute Distributors List
18.3 Artificial Blood Substitute Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Artificial Blood Substitute (2021-2026)
20.2 Global Forecasted Revenue of Artificial Blood Substitute (2021-2026)
20.3 Global Forecasted Price of Artificial Blood Substitute (2015-2026)
20.4 Global Forecasted Production of Artificial Blood Substitute by Region (2021-2026)
20.4.1 North America Artificial Blood Substitute Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Artificial Blood Substitute Production, Revenue Forecast (2021-2026)
20.4.3 Europe Artificial Blood Substitute Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Artificial Blood Substitute Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Artificial Blood Substitute Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Artificial Blood Substitute Production, Revenue Forecast (2021-2026)
20.4.7 Africa Artificial Blood Substitute Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Artificial Blood Substitute Production, Revenue Forecast (2021-2026)
20.4.9 South America Artificial Blood Substitute Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Artificial Blood Substitute Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Artificial Blood Substitute by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Artificial Blood Substitute by Country
21.2 East Asia Market Forecasted Consumption of Artificial Blood Substitute by Country
21.3 Europe Market Forecasted Consumption of Artificial Blood Substitute by Countriy
21.4 South Asia Forecasted Consumption of Artificial Blood Substitute by Country
21.5 Southeast Asia Forecasted Consumption of Artificial Blood Substitute by Country
21.6 Middle East Forecasted Consumption of Artificial Blood Substitute by Country
21.7 Africa Forecasted Consumption of Artificial Blood Substitute by Country
21.8 Oceania Forecasted Consumption of Artificial Blood Substitute by Country
21.9 South America Forecasted Consumption of Artificial Blood Substitute by Country
21.10 Rest of the world Forecasted Consumption of Artificial Blood Substitute by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer